Avonex Articles
Biogen Expects Record Sales And Net Income In 1996
20 January 1997
First Launch Of Teva's Copaxone For Multiple Sclerosis
6 January 1997
Product News In 1996 Dominated By CNS
23 December 1996
Isreali Call For Biotech Venture Capital Fund
16 December 1996
Excellent Year For The Biotechnology Industry
16 December 1996
Biogen Gets OK From EMEA Committee For Avonex
25 November 1996
Overseas Sales Boost Schering AG's Profit
18 November 1996
Teva Tempers Copaxone Profits Expectations
28 October 1996
NEW YORK STOCK COMMENT
21 October 1996
Biogen Posts Record Results In 3rd Qtr
21 October 1996
Berlex vs Biogen Suit Dismissed
14 October 1996
NEW YORK STOCK COMMENT
30 September 1996
FDA Panel Advises Approval Of Teva's Copaxone
30 September 1996
Biogen And Berlex Officials Deposed
9 September 1996
Biogen Signs Up Avonex Distributors
19 August 1996
Biopharmaceutical Firms Report On 2nd Qtr
12 August 1996
NEW YORK STOCK COMMENT
22 July 1996
Berlex And Biogen Battle On Over Interferon Beta
15 July 1996
UK Industry Code of Practice Review
8 July 1996
Biogen Chief Plays Down Berlex Lawsuit
3 June 1996
Interpharm's Profits Fall In 1995
3 June 1996
Europe Stock Comment
27 May 1996
New York Stock Comment
27 May 1996
Biogen Sees First Launch Of MS Drug Avonex
27 May 1996
Ares-Serono's Profits Decline In 1995
25 March 1996
US Clearance For Biogen's Avonex Expected Soon
18 March 1996
Transition For AHP in 1995; Year-End Results
5 February 1996
New York stock comment
8 January 1996
New York Stock Comment
18 December 1995
New York Stock Comment
4 December 1995
European Stock Comment
4 December 1995
Biogen's Interferon Beta Nears US Approval
4 December 1995
New York Stock Comment
27 November 1995
Winners And Losers In US Medicare/Medicaid Reform
20 November 1995
US Drug Cos Reveal Strong Growth In 1995 3rd Qtr
30 October 1995
NEW YORK STOCK COMMENT
23 October 1995
MS: Hope, Expectations, And Disappointments
23 October 1995
New York stock comment
9 October 1995
A-S' Rebif & Frone Offer Dramatic Benefit In MS
26 June 1995
New York stock comment
19 June 1995
Biogen Files For Avonex MS Drug In USA
29 May 1995
Biogen Files For Avonex MS Drug In USA
29 May 1995
Biogen Files For MS Drug In Europe
8 May 1995
World Immunology, Rheumatology Markets
28 November 1994
Ares-Serono Announces Frone Efficacy Data In MS
14 November 1994
Ares-Serono Begins Rebif Production
17 October 1994
ARES-SERONO TO CASH IN DIAGNOSTICS
16 May 1994
NEW THERAPIES FOR MULTIPLE SCLEROSIS
4 April 1994
ARES-SERONO LIFTS MARKET SHARE
29 November 1993
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
